Announcements Trials

Browse Landscape

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Lymphoid 1 Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 616 Oxaliplatin 579 Gemcitabine 492 Capecitabine 445 Leucovorin 427 Irinotecan 390 Bevacizumab 330 Cisplatin 320 Radiotherapy 245 Cetuximab 215 Sorafenib 167 pembrolizumab 150 Docetaxel 150 Paclitaxel 140 Nivolumab 128 Albumin-Bound Paclitaxel 108 130-nm albumin-bound paclitaxel 108 Folfox protocol 101 Panitumumab 95 Erlotinib Hydrochloride 95 Surgical Procedures, Operative 86 regorafenib 84 S 1 (combination) 81 Drug Therapy 80 Radiation 69 Carboplatin 65 Neoadjuvant Therapy 64 Colonoscopy 64 Radiosurgery 62 Surveys and Questionnaires 60

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Amphotericin B × Gastrointestinal × Clear all

NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

40,110 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡